Inhibition of bromodomain containing protein 4 (BRD4) for reversal of idiopathic pulmonary fibrosis
Active Project Grant Awarded Last action
- Award ID
- HT9425261E418
- Recipient
-
University Of Wisconsin System UEI LCLSJAGTNZQ7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $3,087,208
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 6% complete
- Place of performance
- Madison, WI 53715, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded the University of Wisconsin System $3.087 million on August 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on inhibition of bromodomain containing protein 4 (BRD4) for reversal of idiopathic pulmonary fibrosis. The award funds basic and applied biomedical research intended to transform health care for Service Members and the American public through innovative medical solutions. The University of Wisconsin - Madison Division serves as the recipient and will perform the work in Madison, Wisconsin. The project runs through August 14, 2030.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Texas Medical Branch At Galveston | $125,000 |
Quick answers
Who received award HT9425261E418?
HT9425261E418 was awarded to University Of Wisconsin System by Defense Health Agency (Department of Defense) on August 15, 2026.
How much is award HT9425261E418 worth?
$3,087,208 has been obligated on HT9425261E418.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award